Literature DB >> 36258156

The chest pain guidelines revisited: cherry picking from the frequentist tree.

Timothy F Christian1.   

Abstract

The new chest pain guideline document was recently released. The biggest changes are in the recommendations for intermediate and high-risk patients with known and unknown CAD. Coronary CT angiography has been recommended as the preferred imaging test for patients < 65 years old with chest pain. This paper will review the major evidence and omissions in the document that prompted that recommendation and provide thoughts on potential actions going forward.
© 2022. The Author(s) under exclusive licence to American Society of Nuclear Cardiology.

Entities:  

Keywords:  CT; PET; SPECT; diagnostic and prognostic application

Year:  2022        PMID: 36258156     DOI: 10.1007/s12350-022-03109-y

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   3.872


  11 in total

1.  American Society of Nuclear Cardiology position statement on radionuclide imaging in patients with suspected acute ischemic syndromes in the emergency department or chest pain center.

Authors:  Frans J Th Wackers; Kenneth A Brown; Gary V Heller; Michael C Kontos; James L Tatum; James E Udelson; Jack A Ziffer
Journal:  J Nucl Cardiol       Date:  2002 Mar-Apr       Impact factor: 5.952

2.  Selective use of single-photon emission computed tomography myocardial perfusion imaging in a chest pain center.

Authors:  B G Abbott; I Abdel-Aziz; S Nagula; E P Monico; J A Schriver; F J Wackers
Journal:  Am J Cardiol       Date:  2001-06-15       Impact factor: 2.778

3.  Value of acute rest sestamibi perfusion imaging for evaluation of patients admitted to the emergency department with chest pain.

Authors:  M C Kontos; R L Jesse; K L Schmidt; J P Ornato; J L Tatum
Journal:  J Am Coll Cardiol       Date:  1997-10       Impact factor: 24.094

4.  Clinical value of acute rest technetium-99m tetrofosmin tomographic myocardial perfusion imaging in patients with acute chest pain and nondiagnostic electrocardiograms.

Authors:  G V Heller; S A Stowers; R C Hendel; S D Herman; E Daher; A W Ahlberg; J M Baron; C F Mendes de Leon; J A Rizzo; F J Wackers
Journal:  J Am Coll Cardiol       Date:  1998-04       Impact factor: 24.094

5.  Comparison of myocardial perfusion imaging and cardiac troponin I in patients admitted to the emergency department with chest pain.

Authors:  M C Kontos; R L Jesse; F P Anderson; K L Schmidt; J P Ornato; J L Tatum
Journal:  Circulation       Date:  1999-04-27       Impact factor: 29.690

6.  "False-positive" myocardial perfusion scintigraphy findings in patients with angiographically normal coronary arteries: insights from intravascular sonography studies.

Authors:  E Verna; L Ceriani; L Giovanella; G Binaghi; S Garancini
Journal:  J Nucl Med       Date:  2000-12       Impact factor: 10.057

7.  Prognostic value of automated quantification of 99mTc-sestamibi myocardial perfusion imaging.

Authors:  William D Leslie; Shawn A Tully; Marina S Yogendran; Linda M Ward; Khaled A Nour; Colleen J Metge
Journal:  J Nucl Med       Date:  2005-02       Impact factor: 10.057

8.  Harmonizing multimodality imaging results using Bayesian analysis: the case of CT coronary angiography and CT-derived fractional flow reserve.

Authors:  Timothy F Christian; Ravi Marfatia; Lu Q Chen; Afiachukwu G Onuegbu; Simcha Pollack; Jane Cao
Journal:  Int J Cardiovasc Imaging       Date:  2022-01-29       Impact factor: 2.357

9.  Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction.

Authors:  H D White; R M Norris; M A Brown; P W Brandt; R M Whitlock; C J Wild
Journal:  Circulation       Date:  1987-07       Impact factor: 29.690

10.  Noninvasive identification of myocardium at risk in patients with acute myocardial infarction and nondiagnostic electrocardiograms with technetium-99m-Sestamibi.

Authors:  T F Christian; I P Clements; R J Gibbons
Journal:  Circulation       Date:  1991-05       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.